vs

ACADIA PHARMACEUTICALS INC(ACAD)与Fair Isaac(FICO)财务数据对比。点击上方公司名可切换其他公司

Fair Isaac的季度营收约是ACADIA PHARMACEUTICALS INC的1.9倍($512.0M vs $268.1M),Fair Isaac净利率更高(30.9% vs 1.4%,领先29.6%),Fair Isaac同比增速更快(16.4% vs 9.7%),过去两年Fair Isaac的营收复合增速更高(8.6% vs 5.3%)

阿卡迪亚制药是一家总部位于美国加利福尼亚州圣地亚哥德尔马地区的生物制药企业,专注于中枢神经系统相关疾病治疗药物的研发、生产与商业化,致力于为全球患者提供创新的临床治疗方案。

FICO(原Fair, Isaac and Company)是美国知名数据分析企业,1956年由比尔·费尔与厄尔·艾萨克创立,总部位于蒙大拿州博兹曼市,核心业务为信用评分服务,其推出的FICO信用分是评估消费者信贷风险的重要指标,目前已被美国消费信贷行业广泛采用。

ACAD vs FICO — 直观对比

营收规模更大
FICO
FICO
是对方的1.9倍
FICO
$512.0M
$268.1M
ACAD
营收增速更快
FICO
FICO
高出6.6%
FICO
16.4%
9.7%
ACAD
净利率更高
FICO
FICO
高出29.6%
FICO
30.9%
1.4%
ACAD
两年增速更快
FICO
FICO
近两年复合增速
FICO
8.6%
5.3%
ACAD

损益表 — Q1 FY2026 vs Q1 FY2026

指标
ACAD
ACAD
FICO
FICO
营收
$268.1M
$512.0M
净利润
$3.6M
$158.4M
毛利率
83.0%
营业利润率
-1.7%
45.7%
净利率
1.4%
30.9%
营收同比
9.7%
16.4%
净利润同比
3.8%
每股收益(稀释后)
$0.02
$6.61

绿色 = 该指标领先。财年不对齐时期间可能不同

8季度营收与利润趋势

并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配

营收
ACAD
ACAD
FICO
FICO
Q1 26
$268.1M
Q4 25
$284.0M
$512.0M
Q3 25
$278.6M
$515.8M
Q2 25
$264.6M
$536.4M
Q1 25
$244.3M
$498.7M
Q4 24
$259.6M
$440.0M
Q3 24
$250.4M
$453.8M
Q2 24
$242.0M
$447.8M
净利润
ACAD
ACAD
FICO
FICO
Q1 26
$3.6M
Q4 25
$273.6M
$158.4M
Q3 25
$71.8M
$155.0M
Q2 25
$26.7M
$181.8M
Q1 25
$19.0M
$162.6M
Q4 24
$143.7M
$152.5M
Q3 24
$32.8M
$135.7M
Q2 24
$33.4M
$126.3M
毛利率
ACAD
ACAD
FICO
FICO
Q1 26
Q4 25
90.8%
83.0%
Q3 25
92.2%
82.3%
Q2 25
92.2%
83.7%
Q1 25
91.7%
82.4%
Q4 24
91.6%
80.1%
Q3 24
92.5%
80.3%
Q2 24
92.5%
80.3%
营业利润率
ACAD
ACAD
FICO
FICO
Q1 26
-1.7%
Q4 25
6.1%
45.7%
Q3 25
12.8%
46.0%
Q2 25
12.2%
48.9%
Q1 25
7.9%
49.3%
Q4 24
59.1%
40.8%
Q3 24
12.6%
43.4%
Q2 24
12.6%
42.5%
净利率
ACAD
ACAD
FICO
FICO
Q1 26
1.4%
Q4 25
96.3%
30.9%
Q3 25
25.8%
30.1%
Q2 25
10.1%
33.9%
Q1 25
7.8%
32.6%
Q4 24
55.4%
34.7%
Q3 24
13.1%
29.9%
Q2 24
13.8%
28.2%
每股收益(稀释后)
ACAD
ACAD
FICO
FICO
Q1 26
$0.02
Q4 25
$1.61
$6.61
Q3 25
$0.42
$6.41
Q2 25
$0.16
$7.40
Q1 25
$0.11
$6.59
Q4 24
$0.86
$6.14
Q3 24
$0.20
$5.44
Q2 24
$0.20
$5.05

资产负债表与财务实力

最新季度各公司的流动性、杠杆与账面价值一览

指标
ACAD
ACAD
FICO
FICO
现金及短期投资手头流动性
$162.0M
总债务越低越好
$3.2B
股东权益账面价值
$-1.8B
总资产
$1.6B
$1.9B
负债/权益比越低杠杆越低

8季度趋势,按日历期对齐

现金及短期投资
ACAD
ACAD
FICO
FICO
Q1 26
Q4 25
$177.7M
$162.0M
Q3 25
$258.0M
$134.1M
Q2 25
$253.6M
$189.0M
Q1 25
$217.7M
$146.6M
Q4 24
$319.6M
$184.3M
Q3 24
$155.1M
$150.7M
Q2 24
$177.1M
$156.0M
总债务
ACAD
ACAD
FICO
FICO
Q1 26
Q4 25
$3.2B
Q3 25
$3.1B
Q2 25
$2.8B
Q1 25
$2.5B
Q4 24
$2.4B
Q3 24
$2.2B
Q2 24
$2.1B
股东权益
ACAD
ACAD
FICO
FICO
Q1 26
Q4 25
$1.2B
$-1.8B
Q3 25
$917.3M
$-1.7B
Q2 25
$822.4M
$-1.4B
Q1 25
$765.2M
$-1.1B
Q4 24
$732.8M
$-1.1B
Q3 24
$577.2M
$-962.7M
Q2 24
$516.7M
$-829.3M
总资产
ACAD
ACAD
FICO
FICO
Q1 26
$1.6B
Q4 25
$1.6B
$1.9B
Q3 25
$1.3B
$1.9B
Q2 25
$1.2B
$1.9B
Q1 25
$1.1B
$1.8B
Q4 24
$1.2B
$1.7B
Q3 24
$976.9M
$1.7B
Q2 24
$914.1M
$1.7B

现金流与资本效率

扣除再投资后实际产生的现金。现金流比净利润更难造假

指标
ACAD
ACAD
FICO
FICO
经营现金流最新季度
$174.1M
自由现金流经营现金流 - 资本支出
$173.9M
自由现金流率自由现金流/营收
34.0%
资本支出强度资本支出/营收
0.0%
现金转化率经营现金流/净利润
1.10×
过去12个月自由现金流最近4个季度
$750.6M

8季度趋势,按日历期对齐

经营现金流
ACAD
ACAD
FICO
FICO
Q1 26
Q4 25
$-48.7M
$174.1M
Q3 25
$74.3M
$223.7M
Q2 25
$64.0M
$286.2M
Q1 25
$20.3M
$74.9M
Q4 24
$40.4M
$194.0M
Q3 24
$63.2M
$226.5M
Q2 24
$25.0M
$213.3M
自由现金流
ACAD
ACAD
FICO
FICO
Q1 26
Q4 25
$173.9M
Q3 25
$73.9M
$219.5M
Q2 25
$284.4M
Q1 25
$72.8M
Q4 24
$193.2M
Q3 24
$63.2M
$224.7M
Q2 24
$211.6M
自由现金流率
ACAD
ACAD
FICO
FICO
Q1 26
Q4 25
34.0%
Q3 25
26.5%
42.6%
Q2 25
53.0%
Q1 25
14.6%
Q4 24
43.9%
Q3 24
25.2%
49.5%
Q2 24
47.2%
资本支出强度
ACAD
ACAD
FICO
FICO
Q1 26
Q4 25
0.0%
Q3 25
0.1%
0.8%
Q2 25
0.3%
Q1 25
0.4%
Q4 24
0.2%
Q3 24
0.0%
0.4%
Q2 24
0.4%
现金转化率
ACAD
ACAD
FICO
FICO
Q1 26
Q4 25
-0.18×
1.10×
Q3 25
1.03×
1.44×
Q2 25
2.40×
1.57×
Q1 25
1.07×
0.46×
Q4 24
0.28×
1.27×
Q3 24
1.93×
1.67×
Q2 24
0.75×
1.69×

财务流量对比

营收 → 毛利润 → 营业利润 → 净利润流向图

业务分部营收拆解

ACAD
ACAD

暂无分部数据

FICO
FICO

Business To Business Scores$248.6M49%
Saa S Products$115.7M23%
Platform Software$73.9M14%
Business To Consumer Scores$55.9M11%
Technology Service$19.2M4%

相关对比